These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 23090839)
21. Cure of ventriculitis and central nervous system shunt infection by Staphylococcus epidermidis with vancomycin by intraventricular injection in a liver transplant recipient. Schwabe M; Jüttner E; Blaich A; Potthoff K; Pisarski P; Waller CF Transpl Infect Dis; 2007 Mar; 9(1):46-50. PubMed ID: 17313472 [TBL] [Abstract][Full Text] [Related]
22. Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis. Mader MM; Czorlich P; König C; Fuhrmann V; Kluge S; Westphal M; Grensemann J Acta Neurochir (Wien); 2018 Nov; 160(11):2099-2105. PubMed ID: 30242495 [TBL] [Abstract][Full Text] [Related]
23. Treatment Considerations for CNS Infections Caused by Vancomycin-Resistant Lee BJ; Vu BN; Seddon AN; Hodgson HA; Wang SK Ann Pharmacother; 2020 Dec; 54(12):1243-1251. PubMed ID: 32506921 [TBL] [Abstract][Full Text] [Related]
24. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. Chen K; Wu Y; Wang Q; Wang J; Li X; Zhao Z; Zhou J J Crit Care; 2015 Feb; 30(1):218.e1-5. PubMed ID: 25449880 [TBL] [Abstract][Full Text] [Related]
25. Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections? Kumta N; Roberts JA; Lipman J; Cotta MO Clin Pharmacokinet; 2018 Apr; 57(4):439-454. PubMed ID: 28905331 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic drug monitoring of cerebrospinal fluid vancomycin concentration during intraventricular administration. Popa D; Loewenstein L; Lam SW; Neuner EA; Ahrens CL; Bhimraj A J Hosp Infect; 2016 Feb; 92(2):199-202. PubMed ID: 26654472 [TBL] [Abstract][Full Text] [Related]
27. An infant with an MRSA ventriculo-gallbladder shunt infection. Weiner GM; Bui CJ; Steele RW Clin Pediatr (Phila); 2011 Mar; 50(3):269-71. PubMed ID: 21307082 [No Abstract] [Full Text] [Related]
28. Intraventricular vancomycin in pediatric patients with cerebrospinal fluid shunt infections. Al-Jeraisy M; Phelps SJ; Christensen ML; Einhaus S J Pediatr Pharmacol Ther; 2004 Jan; 9(1):36-42. PubMed ID: 23118689 [TBL] [Abstract][Full Text] [Related]
29. Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study. Parasuraman JM; Kloprogge F; Standing JF; Albur M; Heep A Eur J Pharm Sci; 2021 Mar; 158():105643. PubMed ID: 33189901 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections. Ni M; Zhao L; Zhang WJ; Ma JW; Zhang GY; Cui DM; Wang K; Fei YB; Gao L; Shen FM Int J Antimicrob Agents; 2021 Mar; 57(3):106281. PubMed ID: 33465459 [TBL] [Abstract][Full Text] [Related]
31. Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update. Mrowczynski OD; Langan ST; Rizk EB Clin Neurol Neurosurg; 2018 Jul; 170():140-158. PubMed ID: 29800828 [TBL] [Abstract][Full Text] [Related]
32. Serial cytokine profiles in shunt-related ventriculitis treated with intraventricular vancomycin. Laborada G; Cruz F; Nesin M Chemotherapy; 2005 Oct; 51(6):363-5. PubMed ID: 16227692 [TBL] [Abstract][Full Text] [Related]
33. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion. Waineo MF; Kuhn TC; Brown DL J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426 [TBL] [Abstract][Full Text] [Related]
34. Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections. Autmizguine J; Moran C; Gonzalez D; Capparelli EV; Smith PB; Grant GA; Benjamin DK; Cohen-Wolkowiez M; Watt KM Pediatr Infect Dis J; 2014 Oct; 33(10):e270-2. PubMed ID: 24776517 [TBL] [Abstract][Full Text] [Related]
35. Prolonged triple therapy for persistent multidrug-resistant Acinetobacter baumannii ventriculitis. Patel JA; Pacheco SM; Postelnick M; Sutton S Am J Health Syst Pharm; 2011 Aug; 68(16):1527-31. PubMed ID: 21817084 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Pfausler B; Haring HP; Kampfl A; Wissel J; Schober M; Schmutzhard E Clin Infect Dis; 1997 Sep; 25(3):733-5. PubMed ID: 9314470 [TBL] [Abstract][Full Text] [Related]
37. Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review. Beach JE; Perrott J; Turgeon RD; Ensom MHH Clin Pharmacokinet; 2017 Dec; 56(12):1479-1490. PubMed ID: 28528396 [TBL] [Abstract][Full Text] [Related]
38. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis. Nevrekar S; Cunningham KC; Greathouse KM; Panos NG Ann Pharmacother; 2014 Feb; 48(2):274-8. PubMed ID: 24259634 [TBL] [Abstract][Full Text] [Related]
39. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. Arnell K; Enblad P; Wester T; Sjölin J J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527 [TBL] [Abstract][Full Text] [Related]
40. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy. Pfausler B; Spiss H; Beer R; Kampl A; Engelhardt K; Schober M; Schmutzhard E J Neurosurg; 2003 May; 98(5):1040-4. PubMed ID: 12744364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]